Ares Management Corporation

Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, private equity, real estate and infrastructure asset classes. We seek to provide flexible capital to support businesses and create value for our stakeholders and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of March 31, 2023, Ares Management Corporation's global platform had approximately $360 billion of assets under management, with more than 2,600 employees operating across North America, Europe, Asia Pacific and the Middle East. 

For more information, please visit www.aresmgmt.com.

iGlobe Partners

Founded in 1999, iGlobe Partners is a premier venture capital fund manager investing in early-stage technology startups in the areas of Smart Cities, Fintech, Healthtech and Biotech. First established in Silicon Valley and headquartered in Singapore today, the firm has an extensive global network and a strong track record of enabling startups to scale game-changing innovations across geographies. The team has managed funds exceeding US$400 million and has continually delivered top-quartile fund performance to investors, giving rise to multiple unicorns and successful exits including Unity Software (NYSE: U), Twist Bioscience (NASDAQ: TWST), ACSL (TYO: 6232), Matterport (NASDAQ: MTTR), Hippo Holdings (NYSE: HIPO), Ginkgo Bioworks (NYSE: DNA) and NerdWallet (NASDAQ: NRDS).

Investing in Women

Investing in Women, an initiative of the Australian Government, catalyses inclusive economic growth through women’s economic empowerment in South East Asia.

Established in 2016, Investing in Women tackles one of the most critical social and economic issues of our time: gender inequality. Women’s economic empowerment is not only a fundamental aspect of promoting gender equality, but it is vital to enhancing business competitiveness, fuelling inclusive economic growth and building equitable societies.

Investing in Women uses innovative approaches to improve women’s economic participation as employees and as entrepreneurs and to influence the enabling environment to promote women’s economic empowerment in the Philippines, Indonesia, Vietnam and Myanmar through:

• Workplace Gender Equality (WGE) – We support Business Coalitions who work with influential businesses on shifting workplace cultures, practices and policy barriers to achieve WGE
• Impact Investment for Women’s SMEs – We partner with Impact Investors and ecosystem builders to expand market opportunities for women, with a view to incentivising and catalysing access to capital for small and medium enterprises (SMEs) - led by and responsive to the needs of women; and
• Influencing Gender Norms – We work with partners to positively shift attitudes and practices to support women in the world of work.

In collaboration with corporations and business leaders, impact investors, entrepreneurs and advocates, we are working with those who are driving change for women's economic equality in our region.

Investing in Women supports the Sustainable Development Goals (SDGs) 2030 Agenda and the leveraging of private sector investments to achieve the Goals. The SDGs recognise that gender equality is not only an essential human right, but a necessary foundation for peaceful, prosperous and sustainable societies.

TPG

TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $222 billion of assets under management and investment and operational teams around the world. TPG invests across six multi-strategy platforms: Capital, Growth, Impact, TPG Angelo Gordon, Real Estate, and Market Solutions. Our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities.

Quan Capital

Quan capital is a life sciences venture capital firm with global capabilities and strong China expertise. We discover, incubate, and grow next-generation life science companies in early and growth stage, worldwide. Our portfolio companies pioneer differentiated therapies and enabling technologies to address major human diseases with high unmet medical needs.

Quan has offices in Shanghai, Palo Alto and Boston. Our investment professionals combine their strong expertise in both science and business with their diverse experiences in global drug development and healthcare investments, and they leverage their broad network worldwide to help maximize the company’s value across geographies and development stages.